Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes StudyAndrew Schmidt, Deborah B. Doroshow, Ziad Bakouny et al.|Cancer Cell|2020Cited by 72
Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes studyZiad Bakouny, Deborah B. Doroshow, C. Labaki et al.|Annals of Oncology|2022Cited by 33
Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors.Qian Qin, Che‐Kai Tsao, Vaibhav G. Patel et al.|Journal of Clinical Oncology|2020Cited by 16
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysisQian Qin, Che‐Kai Tsao, Himanshu Joshi et al.|Discover Oncology|2022Cited by 12
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J. Shah, William Oh, Vaibhav G. Patel et al.|JNCI Cancer Spectrum|2022Cited by 11